As on Wednesday, Elevance Health Inc (NYSE: ELV) started slowly as it slid -1.95% to $400.11, before settling in for the price of $408.07 at the close. Taking a more long-term approach, ELV posted a 52-week range of $391.02-$567.26.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that the giant of the Healthcare sector posted annual sales growth of 13.24% over the last 5 years. Meanwhile, its Annual Earning per share during the time was 12.18%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 0.12%. This publicly-traded company’s shares outstanding now amounts to $231.93 million, simultaneously with a float of $231.44 million. The organization now has a market capitalization sitting at $92.79 billion. At the time of writing, stock’s 50-day Moving Average stood at $441.91, while the 200-day Moving Average is $506.24.
Elevance Health Inc (ELV) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Healthcare Plans industry. Elevance Health Inc’s current insider ownership accounts for 0.21%, in contrast to 90.31% institutional ownership. According to the most recent insider trade that took place on Oct 18 ’24, this organization’s EVP & President, Commercial sold 7,417 shares at the rate of 432.14, making the entire transaction reach 3,205,182 in total value, affecting insider ownership by 8,423.
Elevance Health Inc (ELV) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 10.2 per share during the current fiscal year.
Elevance Health Inc’s EPS increase for this current 12-month fiscal period is 0.12% and is forecasted to reach 34.95 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 9.01% through the next 5 years, which can be compared against the 12.18% growth it accomplished over the previous five years trading on the market.
Elevance Health Inc (NYSE: ELV) Trading Performance Indicators
Let’s observe the current performance indicators for Elevance Health Inc (ELV). The Stock has managed to achieve an average true range (ATR) of 9.68. Alongside those numbers, its PE Ratio stands at $14.58, and its Beta score is 0.83. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 0.53. Similarly, its price to free cash flow for trailing twelve months is now 106.54.
In the same vein, ELV’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 27.43, a figure that is expected to reach 3.98 in the next quarter, and analysts are predicting that it will be 34.95 at the market close of one year from today.
Technical Analysis of Elevance Health Inc (ELV)
Through scrutinizing the latest numbers posted by the [Elevance Health Inc, ELV], it can be observed that its last 5-days Average volume of 1.68 million was better the volume of 1.19 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 62.80% While, its Average True Range was 8.99.
Raw Stochastic average of Elevance Health Inc (ELV) in the period of the previous 100 days is set at 5.16%, which indicates a major fall in contrast to 38.95% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 18.03% that was lower than 29.45% volatility it exhibited in the past 100-days period.
